de
en
fr
it
Contact
Lawyers News & Publications Practice Areas Legal Tech: WW++ Responsible business practice About us Career

News & Publications

News
















Deals & Cases
11 July 2025

NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform

Deals & Cases
24 June 2025

EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics

Deals & Cases
13 May 2025

Granite Bio Debuts With USD 100 Million of Capital

Deals & Cases
28 January 2025

Walder Wyss advised RhyGaze AG on USD 86m Series A Financing Round

13 December 2024

Lithography von Beyond Gravity wird Teil von ZEISS

Deals & Cases
12 November 2024

Alentis Therapeutics Raises USD 181.4m in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors

Awards & Recognitions
12 September 2024

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

Deals & Cases
22 May 2024

SixPeaks Bio AG debuts with USD 110 million in Funding

Deals & Cases
20 December 2023

Walder Wyss berät P&I Personal & Informatik AG beim Verkauf der Mirus Software AG an Alpha VCX

Deals & Cases
7 December 2023

Axalta Coating Systems Group acquires André Koch AG

Deals & Cases
23 November 2023

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

Deals & Cases
15 November 2023

Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round

Deals & Cases
9 November 2023

Syz Capital und Saturnus Capital investieren in Capture Media

Deals & Cases
7 November 2023

Zusammenschluss von SETEX und Datatex mit Elvaston

Deals & Cases
3 November 2023

CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.

Deals & Cases
16 October 2023

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

Awards & Recognitions
22 September 2023

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

Deals & Cases
14 September 2023

Pierre Fabre Laboratories acquires Vertical Bio AG

Walder Wyss Ltd.

  • Legal Notice
  • Privacy
  • Imprint
  • Cookie settings          
  • startuplaw.ch
  • beschaffungswesen.ch
  • dataprotection.ch
  • lifesciencelaw.ch
  • restructuringlaw.ch
  • notar.ch
  • Linkedin WalderWyss LinkedIn

We use cookies

This website uses cookies to improve your user experience. By remaining on the website, you agree to the use of cookies.

Cookie settings

Here you can allow or block individual cookies:

  • Technically necessary cookies
    Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
  • Cookies for statistics
    Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
  • Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.
    Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.